infLuence Of anovulaTion and menopaUSe on the course of MS

Recruiting

• Conditions: Multiple sclerosis; G35

• Registration Number: DRKS00031183
• Lead Sponsor: Klinik für Neurologie, Universitätsklinikum der Ruhr-Universität Bochum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-02-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 1000

Inclusion Criteria

Written informed consent for participation in the German Multiple Sclerosis Registry.
- Definite MS with determinable course or HIS
- Primary residence in Germany
- Written informed consent for participation in this study

Exclusion Criteria

- MS course not determinable
- Lack of capacity to consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint is the time to reach an EDSS score of 4. This score is collected as part of the patients' clinical routines.

Secondary Outcome Measures

Name	Time	Method
A secondary endpoint is the time to reach an EDSS of 3 and 6. These values are collected as part of the patients' clinical routines.<br>Another secondary endpoint is time to transition to SPMS and patient performance in SDMT.